A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancer

@article{Sawaki1993ATO,
  title={A trial of individual dose intensity and relative performance factors in tegafur maintenance chemotherapy for head and neck cancer},
  author={Shuji Sawaki and Hiroaki Watanabe and T. Shine and Tetsuro Kubota and Sohtaro Komiyama and Toshiro Umezaki and I. Nahm},
  journal={European Archives of Oto-Rhino-Laryngology},
  year={1993},
  volume={250},
  pages={408-411}
}
Tegafur (Sunfural-S), as masked compound of a 5-fluorouracil derivative, was administered orally as a maintenance chemotherapeutic agent at a dose of 600 mg/day in 98 ases of head and neck epithelial cancer. The effectiveness of the drug was evaluated by a statistical method involving two formulae: individual dose intensity (IDI) and relative performance… CONTINUE READING